| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1004202652 |
| P356 | DOI | 10.2165/11593790-000000000-00000 |
| P8608 | Fatcat ID | release_7pbc3qjpknft7kdblzrrujmdmi |
| P698 | PubMed publication ID | 21902292 |
| P50 | author | Alice V. Stanton | Q37629564 |
| Pierre Boutouyrie | Q43266978 | ||
| P2093 | author name string | Stéphane Laurent | |
| Patrick Lacolley | |||
| Marie Briet | |||
| Véronique Regnault | |||
| Azra Mahmud | |||
| P2860 | cites work | Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness | Q21093323 |
| Phenotype and course of Hutchinson-Gilford progeria syndrome | Q24607381 | ||
| Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals | Q28192162 | ||
| Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients | Q33881823 | ||
| Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF [...] | Q33920331 | ||
| Expert consensus document on arterial stiffness: methodological issues and clinical applications | Q33999785 | ||
| New Therapeutic Approaches to Mendelian Disorders | Q34136273 | ||
| Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. | Q34136829 | ||
| Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values' | Q34166955 | ||
| Simvastatin prevents inflammation-induced aortic stiffening and endothelial dysfunction | Q34457410 | ||
| Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study | Q34494252 | ||
| Telomeres and aging | Q34768068 | ||
| Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy | Q80213278 | ||
| Arterial stiffness is related to systemic inflammation in essential hypertension | Q81335099 | ||
| Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study | Q82354836 | ||
| Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension | Q83283659 | ||
| Brachial pressure-independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives | Q83349018 | ||
| Telomere length and its associations with oxidized-LDL, carotid artery distensibility and smoking | Q84337443 | ||
| Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes | Q35051910 | ||
| Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 | ||
| Structural and genetic bases of arterial stiffness. | Q36106134 | ||
| Breakers of advanced glycation end products restore large artery properties in experimental diabetes. | Q36477705 | ||
| Treatment with a farnesyltransferase inhibitor improves survival in mice with a Hutchinson-Gilford progeria syndrome mutation. | Q36494004 | ||
| Genetics of cardiovascular diseases: from single mutations to the whole genome | Q36965496 | ||
| Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease | Q37073587 | ||
| Infliximab improves vascular stiffness in patients with rheumatoid arthritis | Q37245192 | ||
| Genetics and pathophysiology of arterial stiffness | Q37355473 | ||
| The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part I: (Patho)-physiology, rationale and perspective on pulse pressure amplification. | Q37370511 | ||
| The effect of antihypertensive drugs on central blood pressure beyond peripheral blood pressure. Part II: Evidence for specific class-effects of antihypertensive drugs on pressure amplification | Q37370514 | ||
| Anti-inflammatory drugs and statins for arterial stiffness reduction | Q37370516 | ||
| Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention | Q37504463 | ||
| Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension | Q37592887 | ||
| Aldosterone: effects on the kidney and cardiovascular system | Q37710377 | ||
| Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure | Q39305628 | ||
| Improved arterial compliance by a novel advanced glycation end-product crosslink breaker | Q40684856 | ||
| Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering | Q42165612 | ||
| Smoking and caffeine have a synergistic detrimental effect on aortic stiffness and wave reflections | Q42170224 | ||
| Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study | Q43093094 | ||
| Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial | Q43208896 | ||
| Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial | Q43227285 | ||
| Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients | Q43292964 | ||
| Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women | Q43683202 | ||
| Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet | Q43744735 | ||
| Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus | Q43907245 | ||
| A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function | Q43917968 | ||
| Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study | Q44039842 | ||
| Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women | Q44044419 | ||
| Altered hemodynamic response to isosorbide dinitrate in essential hypertension. | Q44190639 | ||
| Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone | Q44228479 | ||
| Progesterone does not influence vascular function in postmenopausal women | Q44460522 | ||
| Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol | Q44722307 | ||
| Nebivolol increases arterial distensibility in vivo. | Q44985645 | ||
| Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients | Q45064729 | ||
| Mechanism of nitrate-induced improvement on arterial compliance depends on vascular territory | Q45115073 | ||
| Effects of hormone replacement therapy or raloxifene on ambulatory blood pressure and arterial stiffness in treated hypertensive postmenopausal women | Q45164551 | ||
| Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus. | Q46009761 | ||
| Selective reduction of central pulse pressure under angiotensin blockage in SHR: role of the fibronectin-alpha5beta1 integrin complex. | Q46020976 | ||
| Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial | Q46076309 | ||
| Effect of dark chocolate on arterial function in healthy individuals | Q46518869 | ||
| Decreased arterial elasticity associated with cardiovascular disease risk factors in the young. Bogalusa Heart Study | Q46615343 | ||
| Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection | Q46626456 | ||
| Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. | Q46632190 | ||
| Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinediones | Q46661427 | ||
| Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women | Q46689651 | ||
| Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart | Q46783976 | ||
| A comparison of atenolol and nebivolol in isolated systolic hypertension | Q46809878 | ||
| Adiponectin and arterial stiffness | Q46859136 | ||
| Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease | Q46989695 | ||
| Effects of estrogen and progestin on aortic size and compliance in postmenopausal women | Q47330840 | ||
| Relationship between C reactive protein and pulse pressure is not mediated by atherosclerosis or aortic stiffness | Q47786751 | ||
| Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin | Q48930769 | ||
| Association between local pulse pressure, mean blood pressure, and large-artery remodeling | Q49074582 | ||
| Opposing effects of ageing on distal and proximal large arteries in hypertensives | Q49161260 | ||
| A strain energy function for arteries accounting for wall composition and structure | Q49163970 | ||
| The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. | Q50062450 | ||
| Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study. | Q51590231 | ||
| Long-term reduction in aortic stiffness: a 5.3-year follow-up in routine clinical practice. | Q51757085 | ||
| Assessment of the distensibility of superficial arteries. | Q52111371 | ||
| Automated detection of local artery wall thickness based on M-line signal processing. | Q52282264 | ||
| Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. | Q53572980 | ||
| Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. | Q55033396 | ||
| VELOCITY OF TRANSMISSION OF THE PULSE-WAVE | Q56595262 | ||
| Assessment of pulse wave velocity | Q56595264 | ||
| Acute modulation of arterial compliance in mild essential hypertension | Q57490673 | ||
| Normal Vascular Aging: Differential Effects on Wave Reflection and Aortic Pulse Wave Velocity | Q57532827 | ||
| Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes | Q57605349 | ||
| Telomere Length as an Indicator of Biological Aging | Q59275532 | ||
| Hormonal Therapy Increases Arterial Compliance in Postmenopausal Women | Q63479559 | ||
| Alteration in the carotid artery wall properties with ageing and high blood pressure level | Q67892313 | ||
| Vessel wall properties of large arteries in uncomplicated IDDM | Q70963027 | ||
| Noninvasive assessment of vascular disease in the lower limbs of diabetics | Q71332255 | ||
| Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM | Q71442189 | ||
| Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study | Q71583147 | ||
| Acute and subacute effects of nicorandil and isosorbide dinitrate on vessel wall properties of large arteries and hemodynamics in healthy volunteers | Q72030126 | ||
| Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats | Q72710459 | ||
| Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure | Q73446467 | ||
| The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial | Q74341144 | ||
| Treatment of elderly patients with isolated systolic hypertension with isosorbide dinitrate in an asymmetric dosing schedule | Q77367997 | ||
| Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men | Q79403981 | ||
| Advanced glycation end-products and arterial stiffness in hypertension | Q79836502 | ||
| P433 | issue | 13 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 1689-1701 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Pharmacological modulation of arterial stiffness | |
| P478 | volume | 71 |
| Q37049840 | Application of speckle-tracking in the evaluation of carotid artery function in subjects with hypertension and diabetes |
| Q38770032 | Arterial (Aortic) Stiffness in Patients with Resistant Hypertension: from Assessment to Treatment |
| Q51001130 | Arterial Destiffening in Previously Untreated Mild Hypertensives After 1 Year of Routine Clinical Management. |
| Q38661611 | Arterial stiffness, atherosclerosis and cardiovascular risk: Pathophysiologic mechanisms and emerging clinical indications |
| Q48027735 | Arterial stiffness, cognitive impairment and dementia: confounding factor or real risk? |
| Q47731710 | Association of arterial stiffness with cognition in patients with Lewy body disorder. |
| Q38113257 | Blood pressure and pulse wave velocity as metrics for evaluating pathologic ageing of the cardiovascular system |
| Q38093775 | Central blood pressure in the management of hypertension: soon reaching the goal? |
| Q85427912 | Coronary artery disease. Are β-blockers truly helpful in patients with CAD? |
| Q90526883 | Determinants of pulse pressure amplification in hypertensive and diabetic patients |
| Q36334505 | Effect of intensive multifactorial treatment compared with routine care on aortic stiffness and central blood pressure among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study |
| Q37277071 | Effects of antihypertensive drugs on arterial stiffness |
| Q45116647 | Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors |
| Q34020664 | Functional vascular study in hypertensive subjects with type 2 diabetes using losartan or amlodipine. |
| Q61711619 | High pulse pressure is not associated with abnormal activation of the renin–angiotensin–aldosterone system in repaired aortic coarctation |
| Q36840262 | Impacts of comorbidities on the association between arterial stiffness and obstructive sleep apnea in the elderly |
| Q37342081 | Increased vascular smooth muscle cell stiffness: a novel mechanism for aortic stiffness in hypertension |
| Q41888223 | Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus |
| Q36463642 | Mechanisms of arterial remodeling: lessons from genetic diseases |
| Q38606872 | Periodontitis and arterial stiffness: a systematic review and meta-analysis |
| Q47162229 | Pulse Wave Analysis by Applanation Tonometry for the Measurement of Arterial Stiffness |
| Q50133565 | Strategies for Achieving Healthy Vascular Aging |
| Q35993667 | Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study |
| Q39238938 | The Link Between Adipose Tissue Renin-Angiotensin-Aldosterone System Signaling and Obesity-Associated Hypertension |
| Q92550084 | The place of ARBs in heart failure therapy: is aldosterone suppression the key? |
| Q92290597 | The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular |
| Q40268802 | The systolic-diastolic difference in carotid stiffness is increased in type 2 diabetes: The Maastricht Study |
| Q26774555 | Therapeutic modification of arterial stiffness: An update and comprehensive review |
| Q57787361 | Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients |
| Q38068360 | Treatment of arterial remodeling in essential hypertension |
| Q38241504 | Treatment of hypertension and metabolic syndrome: lowering blood pressure is not enough for organ protection, new approach-arterial destiffening |
Search more.